A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331
Titel:
A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331
Auteur:
Brown, Patrick A. Ji, Lingyun Xu, Xinxin Devidas, Meenakshi Hogan, Laura Borowitz, Michael J. Raetz, Elizabeth A. Zugmaier, Gerhard Sharon, Elad Gore, Lia Whitlock, James A. Pulsipher, Michael A. Hunger, Stephen P. Loh, Mignon L.